From 1016 opportunities to ΔG-visualization in the binding site

webinar

Thu, 26 Oct 2017, 14:00 CEST (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

From 1016 opportunities to ΔG-visualization in the binding site

Taking “the best of both worlds” is usually desirable but rarely achieveable in real life. In drug discovery it is worse: many solutions — so many choices — but no one software can handle all challenges equally well.
Workflow systems like KNIME® offer you a single interface to a myriad of tools and help you to organize, standardize, and streamline your approach and be best prepared all along the way from 1016 opportunities to visualizing atom-based ΔG-contributions in the binding site. We will show you a number of highly efficient strategies implemented this way. Plus you’ll get those as a blue print for your own solution.

Current news

Tool of the Month - infiniSee xREAL
July 27, 2026 10:57 CEST
This August, Trillions Fit on Your Desktop This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. Most screening campaigns are limited less by ideas than by the size of the catalog you can search. infiniSee xREAL removes that limit. It is the only...
Read on
category
Publications
New Publication: Strategies for Identifying Molecules of Interest in Large Chemical Spaces
July 14, 2026 11:25 CEST
In collaboration with Pfizer, our team recently published a study in the Journal of Chemical Information and Modeling. The work represents fundamental research into molecular similarity, extended to ultra-large, combinatorial Chemical Spaces. Read the Full Publication (Open Access) Which Central Questions Were Addressed? Which similarity-score thresholds are meaningful? How do...
Read on
category
Challenge
Dylan Capitti Fenton Wins Scientific Challenge Summer 2025!
July 13, 2026 11:50 CEST
It is our greatest pleasure to announce the winner of the Summer 2025 edition of the Scientific Challenge: the winner is Dylan Capitti Fenton of California State University, Northridge (Van Nuys, United States) with his project ‘Structure-Based Drug Discovery of Bitter Taste Receptor Agonists for GLP-1 Release’. Focusing on the...
Read on